OsteoPearl VBA System:
Where Nature Meets Technology

Minimally invasive spinal implant designed to stabilize the fracture, and create an environment for restoration and healing.

Anatomic and biologic properties. It acts like bone because it is bone. Not a synthetic foreign object that does not promote healing.

Inspired by the AO Principles of fracture reduction and fixation to restore anatomical relationships, preserve the blood supply to soft tissues and bone, and strive for early and safe mobilization and rehabilitation of the patient.¹ ²

Ovine Animal Study Histology and Micro CT Images Over Time

3 weeks

3 Weeks

6 weeks

6 Weeks

12 weeks

12 Weeks

3 week progression
6 week progression
12 week progression

Why OsteoPearl is Different

The OsteoPearl VBA System is the first and only fully biological solution for treating VCFs.
•Osteogenic: induces natural bone growth
•100% cortical bone introduces structure to combat the effects of osteoporosis
•Eliminates the risk of embolisms associated with cement³
•Holistic, natural, long term health option for patients and physicians
•Biologic Technology: Viable, research-proven healing solution

Biological Allograft Chain Tissue Implant Study

Several locations across the country are currently enrolling patients to participate in the ongoing clinical trial of allograft tissue as a bone void filler. To learn more about this study, you or your doctor may contact the study research staff by referring to its ClinicalTrials.gov identifier (NCT number): NCT04064710

Participating Centers in Our Clinical Study:

References:

  1. Müller ME, M Allgöwer, R Schneider, H Willenegger. Manual of Internal Fixation.
    3rd ed. Berlin, Heidelberg, New York: Springer. 1991.
  2. Rüedi TP, RE Buckley, CG Moran. AO Principles of Fracture Management. 2nd ed.
    Stuttgart, New York: Thieme. 2007.
  3. Douglas P. Beall, MD, M. R. Chambers, MD, Sam Thomas, John Amburgy, MD. Prospective and Multicenter Evaluation of Outcomes for Quality of Life and Activities of Daily Living for Balloon Kyphoplasty in the Treatment of Vertebral Compression Fractures: The EVOLVE Trial